Retinoid X receptor alpha and Retinoid X receptor gamma (RXR-alpha and RXR-gamma)

Retinoid X receptor alpha (RXR-alpha, encoded by the RXRA gene) and Retinoid X receptor gamma (RXR-gamma, encoded by the RXRG gene) are members of the nuclear receptor subfamily that serve as coregulators for many other nuclear receptors[1][2][3][4][5][6]. They act by binding as homodimers or as heterodimers to DNA response elements, controlling gene transcription in response to retinoids and other ligands. RXRs are widely expressed, organ-specific, and play crucial roles in metabolism, cellular proliferation, differentiation, signal transduction, and disease etiologies. Their unique capacity to partner with retinoic acid receptor (RAR), peroxisome proliferator-activated receptor (PPAR), liver X receptor (LXR), thyroid hormone receptor (TR), and vitamin D receptor (VDR) makes them central hubs in metabolic and cell regulatory pathways[3][4][5][6]. Their modulation by synthetic drugs (rexinoids) is an area of active pharmaceutical development, but safety concerns including metabolic disturbances and hepatotoxicity must be managed carefully.

Other names

Retinoid X receptor alpha: NR2B1, RXRARetinoid X receptor gamma: NR2B3, RXRG

Agonism/antagonism of RXR leads to modified transcription of target genes Modulation of RXR dimers (with RAR, PPAR, VDR, TR) alters metabolic, proliferative, and differentiation pathways RXR activation can result in increased fatty acid oxidation, altered cholesterol homeostasis, anti-inflammatory and antiproliferative effects